These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2079179)

  • 1. [Arterial hypertension, insulin resistance, and cardiovascular diseases].
    Ferrannini E
    G Ital Cardiol; 1990 Sep; 20(9):791-4. PubMed ID: 2079179
    [No Abstract]   [Full Text] [Related]  

  • 2. [Non-hemodynamic mechanisms of cardiovascular risk in the hypertensive patient: insulin resistance].
    Rendina V; Iaccarino G; Iovino G; Morisco C; Vecchione C; Trimarco B
    Cardiologia; 1994 Dec; 39(12 Suppl 1):295-8. PubMed ID: 7634286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin, nitric oxide and the sympathetic nervous system: from crossroads to metabolic and cardiovascular homeostasis].
    Sartori C; Thalmann S; Jayet PY; Duplain H; Vollenweider P; Scherrer U
    Rev Med Suisse Romande; 2004 Oct; 124(10):635-8. PubMed ID: 15573509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetes mellitus--a risk factor for cardiovascular diseases].
    Skrha J
    Vnitr Lek; 2001 May; 47(5):281-4. PubMed ID: 11395868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microalbuminuria, arterial hypertension and the cardiovascular risk].
    Pedrinelli R; Dell'Omo G; Mariani M
    Cardiologia; 1998 Oct; 43(10):1037-43. PubMed ID: 9922567
    [No Abstract]   [Full Text] [Related]  

  • 6. [Insulin and arterial hypertension: role of hypersympathicotonia].
    Oganov RG; Aleksandrov A
    Ter Arkh; 2002; 74(12):5-7. PubMed ID: 12577828
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin resistance in hypertension and cardiovascular disease.
    Lamounier-Zepter V; Ehrhart-Bornstein M; Bornstein SR
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):355-67. PubMed ID: 16980199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and hypertension. Patients in double jeopardy for cardiovascular disease.
    McLaughlin T; Reaven G
    Geriatrics; 2000 Jun; 55(6):28-32, 35. PubMed ID: 10872343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of vascular disease in hypertension with special reference to diabetes.
    Yudkin JS
    Semin Vasc Med; 2002 May; 2(2):139-48. PubMed ID: 16222605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].
    Mancia G; Seravalle G; Grassi G
    Ann Ital Med Int; 1997; 12(4):217-22. PubMed ID: 9773576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance: the clinical spectrum.
    Mantzoros CS; Flier JS
    Adv Endocrinol Metab; 1995; 6():193-232. PubMed ID: 7671097
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial stiffness and insulin resistance.
    Westerbacka J; Yki-Järvinen H
    Semin Vasc Med; 2002 May; 2(2):157-64. PubMed ID: 16222607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease.
    Reaven GM
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2399-403. PubMed ID: 12788834
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular risk factors in the metabolic syndrome: impact of insulin resistance on lipids, hypertension, and the development of diabetes and cardiac events.
    Zarich SW
    Rev Cardiovasc Med; 2005; 6(4):194-205. PubMed ID: 16379015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle, cardio-metabolic risk and arterial stiffness.
    Duda-Seiman DM; Mancaş S; Gaită D; Drăgan S; Velimirovici D; Iurciuc S; Sarău CA; Iurciuc M; Rada M; Petcov B
    Rom J Intern Med; 2008; 46(1):39-45. PubMed ID: 19157269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperinsulinism--a new pathogenic cause of cardiovascular diseases].
    Kúseková M; Sasinka M
    Cesk Pediatr; 1993 Mar; 48(3):136-40. PubMed ID: 8495516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cardiovascular events in hypertensive patients with insulin resistance: a 13-year follow-up.
    Bigazzi R; Bianchi S; Buoncristiani E; Campese VM
    Nutr Metab Cardiovasc Dis; 2008 May; 18(4):314-9. PubMed ID: 17368007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.